{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:01:17Z","timestamp":1776427277645,"version":"3.51.2"},"reference-count":51,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":846,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.fertnstert.2019.09.033","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T18:49:41Z","timestamp":1582570181000},"page":"400-407.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Impact of extent and biochemical parameters of lymphoma on fertility preservation outcome"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7901-3370","authenticated-orcid":false,"given":"Alexander","family":"Volodarsky-Perel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Togas","family":"Tulandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weon-Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Khojah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Buckett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2019.09.033_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0140-6736(12)60605-9","article-title":"Non-Hodgkin lymphoma","volume":"380","author":"Shankland","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0140-6736(16)32407-2","article-title":"Non-Hodgkin lymphoma","volume":"390","author":"Armitage","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.pop.2016.07.012","volume":"43","author":"Mugnaini","year":"2016","journal-title":"Lymphoma. Prim Care"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib4","doi-asserted-by":"crossref","first-page":"e2014048","DOI":"10.4084\/mjhid.2014.048","article-title":"Epidemiological overview of Hodgkin lymphoma across the Mediterranean basin","volume":"6","author":"Salati","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-13150-4_1","article-title":"Epidemiology and etiology of non-Hodgkin lymphoma","volume":"165","author":"Chiu","year":"2015","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib6","first-page":"2051","article-title":"Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response","volume":"33","author":"Alvarez","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.fertnstert.2012.06.007","article-title":"Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation","volume":"98","author":"Almog","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib8","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.fertnstert.2011.10.014","article-title":"Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis","volume":"97","author":"Friedler","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib9","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.rbmo.2018.01.016","article-title":"Prospective assessment of follicular growth and the oocyte cohort after ovarian stimulation for fertility preservation in 90 cancer patients versus 180 matched controls","volume":"6","author":"Decanter","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib10","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s10815-018-1227-0","article-title":"Fertility preservation: ovarian response to freeze oocytes is not affected by different malignant diseases: an analysis of 992 stimulations","volume":"35","author":"Von Wolff","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10815-012-9787-x","article-title":"Recommendations for fertility preservation in patients with lymphomas. ISFP Practice Committee","volume":"29","author":"Schmidt","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/humrep\/dep346","article-title":"Embryo development of fresh \u2018versus\u2019 vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study","volume":"25","author":"Rienzi","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.fertnstert.2009.02.067","article-title":"Delivery rate using cryopreserved oocytes is comparable to conventional in\u00a0vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients","volume":"93","author":"Grifo","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib15","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib16","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib17","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1586\/ehm.10.70","article-title":"The impact of lymphoma and treatment on male fertility","volume":"3","author":"Eghbali","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1023\/A:1026443510493","article-title":"Characteristics of cryopreserved semen from men with lymphoma","volume":"17","author":"Hallak","year":"2000","journal-title":"J Assist Reprod Genet"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2019.09.033_bib19","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ejogrb.2003.11.024","article-title":"Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania","volume":"113","author":"Chung","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1023\/A:1012464703805","article-title":"Male gonadal dysfunction in patients with Hodgkin\u2019s disease prior to treatment","volume":"12","author":"Rueffer","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.fertnstert.2012.04.021","article-title":"Reduced pretreatment ovarian reserve in premenopausal female patients with Hodgkin lymphoma or non-Hodgkin-lymphoma\u2014evaluation by using antim\u00fcllerian hormone and retrieved oocytes","volume":"98","author":"Lawrenz","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib22","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10815-016-0689-1","article-title":"Female patients with lymphoma demonstrate diminished ovarian reserve even before initiation of chemotherapy when compared with healthy controls and patients with other malignancies","volume":"33","author":"Lekovich","year":"2016","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib23","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.fertnstert.2016.06.035","article-title":"High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma","volume":"106","author":"Paradisi","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib24","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib25","doi-asserted-by":"crossref","first-page":"e2014053","DOI":"10.4084\/mjhid.2014.053","article-title":"Prognostic factors in Hodgkin lymphoma","volume":"6","author":"Cuccaro","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1182\/asheducation-2006.1.295","article-title":"Optimal use of prognostic factors in non-Hodgkin lymphoma","author":"Sehn","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib27","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin\u2019s disease: international prognostic factors project on advanced Hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib28","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib29","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.5858\/134.3.326","article-title":"The 2009 version of the cancer protocols of the College of American Pathologists","volume":"134","author":"Amin","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.fertnstert.2003.07.027","article-title":"Comparison of two different starting multiple dose gonadotropin-releasing hormone antagonist protocols in a selected group of in\u00a0vitro fertilization-embryo transfer patients","volume":"81","author":"Escudero","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib32","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1472-6483(10)61661-6","article-title":"Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol","volume":"10","author":"Al-Inany","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib33","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.fertnstert.2013.07.1992","article-title":"Effective method for emergency fertility preservation: random-start controlled ovarian stimulation","volume":"100","author":"Cakmak","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.fertnstert.2016.09.041","article-title":"Immature oocyte retrieval and in\u00a0vitro oocyte maturation at different phases of the menstrual cycle in women with cancer who require urgent gonadotoxic treatment","volume":"107","author":"Creux","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib35","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1016\/j.fertnstert.2008.04.014","article-title":"Obstetric outcomes following vitrification of in\u00a0vitro and in\u00a0vivo matured oocytes","volume":"91","author":"Chian","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/humrep\/dey216","article-title":"The impact of cancer on subsequent chance of pregnancy: a population-based analysis","volume":"33","author":"Anderson","year":"2018","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib37","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/humrep\/dey382","article-title":"Effects of cancer stage and grade on fertility preservation outcome and ovarian stimulation response","volume":"34","author":"Volodarsky-Perel","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-7207(02)00054-0","article-title":"Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors","volume":"191","author":"Smith","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bbrc.2011.01.109","article-title":"Integrin \u03b1\u03b21, \u03b1v\u03b2, \u03b16\u03b2 effectors p130Cas, Src and talin regulate carcinoma invasion and chemoresistance","volume":"406","author":"Sansing","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib40","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/bjc.2014.90","article-title":"Cancer and systemic inflammation: treat the tumour and treat the host","volume":"110","author":"Roxburgh","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib41","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1038\/onc.2010.172","article-title":"Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-\u03b21-mediated growth suppression in adult T-cell leukemia\/lymphoma","volume":"29","author":"Nakahata","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1034\/j.1600-0609.2002.01609.x","article-title":"Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin\u2019s lymphoma","volume":"68","author":"Niitsu","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1084\/jem.172.1.121","article-title":"Transactivation of the transforming growth factor beta 1 (TGF-\u03b21) gene by human T lymphotropic virus type 1 tax: a potential mechanism for the increased production of TGF-beta 1 in adult T cell leukemia","volume":"172","author":"Kim","year":"1990","journal-title":"J Exp Med"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib44","doi-asserted-by":"crossref","first-page":"e289","DOI":"10.3399\/bjgp15X684805","article-title":"Quantifying the risk of Hodgkin lymphoma in symptomatic primary care patients aged \u226540 years: a case-control study using electronic records","volume":"65","author":"Shephard","year":"2015","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2407-9-153","article-title":"Inflammatory (B) symptoms are independent predictors of myelosuppression from chemotherapy in non-hodgkin lymphoma (NHL) patients\u2014analysis of data from a British National Lymphoma Investigation phase III trial comparing CHOP to PMitCEBO","volume":"9","author":"Sharma","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib46","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood-2014-03-537506","article-title":"Paraneoplastic neurological syndromes in Hodgkin and non-Hodgkin lymphomas","volume":"123","author":"Graus","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3389\/fonc.2017.00145","article-title":"Epithelial-to-mesenchymal transition in the female reproductive tract: from normal functioning to disease pathology","volume":"7","author":"Bilyk","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib48","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/bies.10155","article-title":"Defining the actions of transforming growth factor beta in reproduction","volume":"24","author":"Ingman","year":"2002","journal-title":"Bioessays"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2009.24.2057","article-title":"Association of BRCA1 mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast\/ovarian cancer risks","volume":"28","author":"Oktay","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib50","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.fertnstert.2011.06.071","article-title":"Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic ovaries","volume":"96","author":"Holte","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2019.09.033_bib51","first-page":"CD008046","article-title":"Gonadotropin-releasing hormone agonist versus hCG for oocyte triggering in antagonist-assisted reproductive technology","volume":"10","author":"Youssef","year":"2014","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028219324598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028219324598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T08:24:52Z","timestamp":1758011092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028219324598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0015028219324598"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.09.033","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of extent and biochemical parameters of lymphoma on fertility preservation outcome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2019.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92019 American Society for Reproductive Medicine, Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}